| 17.41 Data as of May 17 |  -0.08 / -0.46%Today’s Change | 12.53 Today|||52-Week Range 19.96 | +21.66% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $442.6M |
Company Description
Fluidigm Corp. develops, manufactures and markets microfluidic systems for growth markets such as single-cell genomics, applied genotyping and sample preparation for targeted resequencing, in the life science and agricultural biotechnology, or Ag-Bio, industries. Its proprietary microfluidic systems consist of instruments and consumables, including chips, assays and other reagents that are designed to overcome many of the limitations of conventional laboratory systems by integrating a vast number of fluidic components on a single microfabricated chip. The company was founded by Stephen R. Quake & Gajus V. Worthington on May 19, 1999 and is headquartered in South San Francisco, CA.
Employees
Shareholders
| Mutual fund holders | 52.37% |
| Other institutional | 34.97% |
| Individual stakeholders | 1.27% |
Top Executives
| Gajus Vincent Worthington | President, Chief Executive Officer & Director |
| Fredric T. Walder | Chief Operating Officer |
| Vikram Jog, MBA, CPA | Chief Financial Officer |
| Robert C. Jones | Executive Vice President-Research & Development |
| Un K. Kwon-Casado | Vice President-Corporate Development |
.
